Brady Lee Stein

  • 1301 Citations

Research output per year

If you made any changes in Pure these will be visible here soon.

Personal profile

Certifications and Licenses

Internal Medicine

Training Experience

2006Residency, Johns Hopkins Hospital
2010Fellowship, Johns Hopkins Hospital

Education/Academic qualification

MD, Emory University

… → 2003

Research interests

  • Anemia
  • Aplastic Anemia
  • Chronic Leukemias
  • Clotting Disorders
  • Hematological Disorders
  • Hematological Malignancies
  • Hemostasis
  • Immune-Mediated Cytopenias
  • Low Platelet Count
  • Myelodysplastic Syndrome
  • Myeloproliferative Diseases
  • Phlebitis
  • Platele

Fingerprint Dive into the research topics where Brady Lee Stein is active. These topic labels come from the works of this person. Together they form a unique fingerprint.

  • 9 Similar Profiles

Network Recent external collaboration on country level. Dive into details by clicking on the dots.


Research Output

Long-term antithrombotic therapy after venous stent placement

Lin, C., Martin, K. A., Wang, M., Stein, B. L. & Desai, K. R., Jul 1 2020, In : Phlebology. 35, 6, p. 402-408 7 p.

Research output: Contribution to journalArticle

  • Thrombocytosis and Thrombosis: Is There Really a Correlation?

    Galvez, C. & Stein, B. L., Aug 1 2020, In : Current Hematologic Malignancy Reports. 15, 4, p. 261-267 7 p.

    Research output: Contribution to journalReview article

  • Treatment Patterns and Blood Counts in Patients With Polycythemia Vera Treated With Hydroxyurea in the United States: An Analysis From the REVEAL Study

    Grunwald, M. R., Kuter, D. J., Altomare, I., Burke, J. M., Gerds, A. T., Walshauser, M. A., Savona, M. R., Stein, B., Oh, S. T., Colucci, P., Parasuraman, S., Paranagama, D. & Mesa, R., Apr 2020, In : Clinical Lymphoma, Myeloma and Leukemia. 20, 4, p. 219-225 7 p.

    Research output: Contribution to journalArticle

    Open Access
  • ASXL1 mutations in idiopathic cytopenias: determined significance?

    Galvez, C. & Stein, B. L., Feb 23 2019, In : Leukemia and Lymphoma. 60, 3, p. 568-570 3 p.

    Research output: Contribution to journalComment/debate

    Aurora kinase A inhibition provides clinical benefit, normalizes megakaryocytes, and reduces bone marrow fibrosis in patients with myelofibrosis: A phase I trial

    Gangat, N., Marinaccio, C., Swords, R., Watts, J. M., Gurbuxani, S., Rademaker, A., Fought, A. J., Frankfurt, O., Altman, J. K., Wen, Q. J., Farnoud, N., Famulare, C. A., Patel, A., Tapia, R., Vallapureddy, R. R., Barath, S., Graf, A., Handlogten, A., Zblewski, D., Patnaik, M. M. & 14 others, Al-Kali, A., Dinh, Y. T., Prahl, K. E., Patel, S., Nobrega, J. C., Tejera, D., Thomassen, A., Gao, J., Ji, P., Rampal, R. K., Giles, F. J., Tefferi, A., Stein, B. & Crispino, J. D., Aug 15 2019, In : Clinical Cancer Research. 25, 16, p. 4898-4906 9 p.

    Research output: Contribution to journalArticle

  • 16 Scopus citations